MYC and lymphoma: Moreover, there was considerable overlap between those proteins observed to be down-regulated in WT cells upon treatment with CCT244747 and the cohort of proteins at comparatively lower levels in Eμ-Myc/cRel−/− lymphomas without CHK1i treatment (Figure 2G, Supplementary Data File S3).